Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26F6RY1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,645
Award facts
- Contract value 100% obligated
- $45,644.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of NURTEC ODT 75 mg tablets (quantity: 8 units) under a firm fixed-price arrangement. Valued at $45,644.72 with an ultimate completion date of January 2, 2026, this non-set-aside contract represents a competitively awarded procurement for pharmaceutical support to federal healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing critical medical supplies to military and veteran healthcare programs.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion vehicle extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally. The contract supports military healthcare programs through flexible ordering arrangements and demonstrates the contractor's capability to fulfill federal procurement requirements across multiple therapeutic domains, including neurological treatments such as NURTEC ODT, which is used for migraine management. This delivery order exemplifies the operational structure of the DLA's pharmaceutical prime vendor program, which leverages existing indefinite delivery contracts to meet ongoing medical supply needs across the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6RY1?
SPE2DR26F6RY1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F6RY1 worth?
The government has obligated $45,645 on SPE2DR26F6RY1.
Is contract SPE2DR26F6RY1 an order under another contract?
Yes. SPE2DR26F6RY1 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6RY1 competed?
The extent of competition for SPE2DR26F6RY1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award